Maxim Group Resumes MediciNova (MNOV) at Buy, PT $6 Mar 23, 2026 07:27AM
H.C. Wainwright Starts MediciNova (MNOV) at Buy Mar 16, 2026 06:07AM
MediciNova enrolls 100 patients in ALS drug expanded access study Jan 29, 2026 06:01PM
MediciNova enters $50 million equity distribution agreement with Lucid Dec 30, 2025 07:55AM
MediciNova completes patient enrollment for neuropathy prevention study Dec 18, 2025 06:01AM


Dec 5, 2025 04:27PM Medicinova (MNOV) files $300M mixed shelf
Nov 18, 2025 06:01AM MediciNova appoints Dr. Christopher Breder as clinical advisor
Sep 22, 2025 08:03AM MediciNova completes patient enrollment in ALS drug trial
Sep 8, 2025 09:02AM MediciNova achieves target enrollment for ALS trial, secures $30M equity line
Aug 22, 2025 04:27PM Medicinova (MNOV) Files for 25M Share Offering by Selling Stockholders
Jul 31, 2025 07:31PM Medicinova (MNOV) Signs Standby Equity Purchase Agreement for up to $30 Million
Jul 24, 2025 06:01AM MediciNova nears completion of two clinical trial enrollments
Dec 2, 2024 07:18AM D. Boral Capital Starts MediciNova (MNOV) at Buy
Nov 19, 2024 09:02AM Medicinova (MNOV) CEO Issues Letter to Shareholders